File Download
 
Links for fulltext
(May Require Subscription)
  • Find via
 
Supplementary

Conference Paper: A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection
  • Basic View
  • Metadata View
  • XML View
TitleA phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection
 
AuthorsYuen, RMF
Kim, J
Wong, DKH
Ngai, WS
Yuen, JCH
Lai, CL
 
Issue Date2003
 
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/antiviral
 
ISSN0166-3542
2012 Impact Factor: 3.925
2012 SCImago Journal Rankings: 1.169
 
DC FieldValue
dc.contributor.authorYuen, RMF
 
dc.contributor.authorKim, J
 
dc.contributor.authorWong, DKH
 
dc.contributor.authorNgai, WS
 
dc.contributor.authorYuen, JCH
 
dc.contributor.authorLai, CL
 
dc.date.accessioned2010-09-25T20:46:06Z
 
dc.date.available2010-09-25T20:46:06Z
 
dc.date.issued2003
 
dc.identifier.hkuros130912
 
dc.identifier.issn0166-3542
2012 Impact Factor: 3.925
2012 SCImago Journal Rankings: 1.169
 
dc.identifier.openurl
 
dc.identifier.urihttp://hdl.handle.net/10722/102819
 
dc.languageeng
 
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/antiviral
 
dc.relation.ispartofAntiviral Research
 
dc.rightsAntiviral Research. Copyright © Elsevier BV.
 
dc.titleA phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Yuen, RMF</contributor.author>
<contributor.author>Kim, J</contributor.author>
<contributor.author>Wong, DKH</contributor.author>
<contributor.author>Ngai, WS</contributor.author>
<contributor.author>Yuen, JCH</contributor.author>
<contributor.author>Lai, CL</contributor.author>
<date.accessioned>2010-09-25T20:46:06Z</date.accessioned>
<date.available>2010-09-25T20:46:06Z</date.available>
<date.issued>2003</date.issued>
<identifier.issn>0166-3542</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/102819</identifier.uri>
<language>eng</language>
<publisher>Elsevier BV. The Journal&apos;s web site is located at http://www.elsevier.com/locate/antiviral</publisher>
<relation.ispartof>Antiviral Research</relation.ispartof>
<rights>Antiviral Research. Copyright &#169; Elsevier BV.</rights>
<title>A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection</title>
<type>Conference_Paper</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0166-3542&amp;volume=&amp;spage=&amp;epage=&amp;date=2003&amp;atitle=A+phase+I/IIa,+double-blind,+randomized,+placebo-controlled+trial+of+a+novel+antiviral+agent,+LB80380+in+patients+with+chronic+hepatitis+B+infection</identifier.openurl>
<identifier.hkuros>130912</identifier.hkuros>
</item>